Research on immunotherapy for cancer is ongoing, with studies exploring its potential in treating various types of cancer, including breast, prostate, lung, brain, and bladder cancer. Some studies have reported promising results, such as the use of silica particles in mice with prostate cancer and a new approach to treating a deadly form of brain cancer. The development of tools, such as an ai tool to predict response to immunotherapy drugs, and the investigation of effective adoptive cell immunotherapy, are also being investigated to improve cancer treatment.